Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001697751-19-000001
Filing Date
2019-06-17
Accepted
2019-06-17 16:41:02
Documents
1
Effectiveness Date
2019-06-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10693
  Complete submission text file 0001697751-19-000001.txt   11848
Mailing Address 301 WEST 29TH STREET, SUITE 2004 BALTIMORE MD 21211
Business Address 301 WEST 29TH STREET, SUITE 2004 BALTIMORE MD 21211 610-212-1217
AsclepiX Therapeutics, Inc. (Filer) CIK: 0001697751 (see all company filings)

EIN.: 832160334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-324393 | Film No.: 19901787